
Simone Minnie
@simone_minnie
Postdoc @fredhutch | Hill Lab | #Myeloma Research | #Immunotherapy | #BMT | Opinions are my own 👩🏻🔬🇦🇺
ID: 2235973562
https://www.researchgate.net/profile/Simone_Minnie 08-12-2013 12:24:57
1,1K Tweet
751 Followers
381 Following


What factors enable CAR-Ts to respond to checkpoint blockade, and can they be engineered to be more sensitive to enhancement? We explore this question in our lab’s first pre-print, led by MSTP student AJ Snyder with great collaborations with Evan Newell and Scott Furlan. 1/


Treating the untreatable - "Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure" Penn Medicine @nejm #immunotherapy nejm.org/doi/full/10.10…



The most impressive myeloma abstract at #ASCO25 Outstanding longterm efficacy with cilta-cel CAR-T. 5 year survival rate 50% 5 year PFS rate of 33% Astounding given multi-drug relapsed refractory setting. Plasma Cell Pete Noopur Raje Tom Martin Yi Lin Deepu Madduri





An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses Science Immunology ChrisHunter science.org/doi/10.1126/sc…


Members of IMWG gather to discuss the top priorities for research & clinical programs in the myeloma community. This collaborative group of experts address key topics that can improve outcomes for myeloma patients globally. #IMFIMWG Ajai Chari






Excited to share our Cancer Cell Cell Press article on the discovery of the IL-15 Receptor "Regulome". A technical tour-de-force from the Immunology, computational biology & functional genomics teams oNKo-innate Monash Biomedicine Discovery Institute